MedTrace Logo

Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

NCT00570843 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-02-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.

Conditions

  • Comfort, Vision and Wear Time

Interventions

DRUG

New PEG based artificial tear

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

DRUG

Optive

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

Sponsors & Collaborators

  • Bp Consulting, Inc

    lead NETWORK

Principal Investigators

  • Chris Starr, MD · The New York Presbyterian Hospital Weill Cornell Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570843 on ClinicalTrials.gov